A Comparison of
Child
Female
Fluorodeoxyglucose F18
Humans
Lymph Nodes
/ diagnostic imaging
Lymphatic Metastasis
/ diagnostic imaging
Magnetic Resonance Imaging
Male
Neoplasm Staging
Positron Emission Tomography Computed Tomography
Positron-Emission Tomography
Radiopharmaceuticals
Sensitivity and Specificity
Tomography, X-Ray Computed
Head and neck tumours
PET/CT
PET/MRI
cancer staging
hybrid imaging
lymph node
Journal
In vivo (Athens, Greece)
ISSN: 1791-7549
Titre abrégé: In Vivo
Pays: Greece
ID NLM: 8806809
Informations de publication
Date de publication:
Historique:
received:
27
03
2020
revised:
08
04
2020
accepted:
09
04
2020
entrez:
2
7
2020
pubmed:
2
7
2020
medline:
22
6
2021
Statut:
ppublish
Résumé
The aim of the study was to evaluate the yields of 2-deoxy-2-[ A total of 90 patients (66 men and 24 women) met the inclusion criteria. Preoperative staging was performed: 53 examinations using PET/CT and 37 using PET/MRI. For PET/MRI, the study demonstrated a sensitivity of 89%, specificity of 64%, positive predictive value of 85%, and negative predictive value of 70%; PET/CT had a sensitivity of 95%, specificity 47%, positive predictive value of 82%, and negative predictive value of 78%. Both methods have a high yield in N-clinical staging with statistically insignificant differences. We assume PET/MRI to be the first-choice method in organ-targeted examinations, for pediatric patients and repeat examinations. In cases of MRI contraindication, PET/CT can be used with no impact on the quality of care.
Identifiants
pubmed: 32606177
pii: 34/4/2029
doi: 10.21873/invivo.12002
pmc: PMC7439898
doi:
Substances chimiques
Radiopharmaceuticals
0
Fluorodeoxyglucose F18
0Z5B2CJX4D
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
2029-2032Informations de copyright
Copyright© 2020, International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved.
Références
PLoS One. 2020 Feb 26;15(2):e0229266
pubmed: 32101560
Eur Radiol. 2011 Nov;21(11):2425-6
pubmed: 21698462
J Med Imaging Radiat Oncol. 2015 Oct;59(5):578-85
pubmed: 26178307
J Med Imaging (Bellingham). 2017 Jan;4(1):011013
pubmed: 28401173
Eur J Nucl Med Mol Imaging. 2014 Mar;41(3):462-75
pubmed: 24108458
Eur J Nucl Med Mol Imaging. 2009 Mar;36 Suppl 1:S113-20
pubmed: 19104802
Curr Opin Oncol. 2009 May;21(3):194-200
pubmed: 19363341
Eur J Nucl Med Mol Imaging. 2014 Apr;41(4):639-48
pubmed: 24292211
Laryngorhinootologie. 2020 Jan;99(1):12-21
pubmed: 31935754
Insights Imaging. 2011 Jun;2(3):235-246
pubmed: 22347950
Int J Radiat Oncol Biol Phys. 2005 Apr 1;61(5):1385-92
pubmed: 15817341
J Magn Reson Imaging. 2007 Dec;26(6):1626-33
pubmed: 17968896
AJNR Am J Neuroradiol. 2014 Oct;35(10):1970-5
pubmed: 24924545
Clin Radiol. 2018 Jan;73(1):60-69
pubmed: 29029767
Cancers (Basel). 2020 Feb 22;12(2):
pubmed: 32098356
J Clin Oncol. 2006 Sep 20;24(27):4371-6
pubmed: 16983105
Pediatr Radiol. 2010 May;40(5):681-6
pubmed: 19967534
Clin Nucl Med. 2011 Jul;36(7):518-25
pubmed: 21637051